Practice Connect briefing
Where the 2026/27 GP Contract Money Really Goes
A practical guide to the income gains, hidden losses, QOF shifts and workforce opportunities inside the 2026/27 GP contract.
£485 million is stated in the headline. What matters to practices is much simpler: what should you model before assuming your position improves, where does that money actually go, and which income streams vanish?
While there is actual new funding in the 2026–2027 package, some prominent 2025–2026 revenue streams are eliminated. Advice and guidance ceases to be an enhanced service that must be paid for separately. Referrals for weight management are now paid in QOF rather than on an item basis. Funding for PCN Capacity and Access is transferred to a new GP reimbursement program at the practice level that is connected to same-day, urgent access.
The largest operational and financial changes from April 2026 are described in this article along with what has been confirmed, what has not yet been published, and what PCN leaders should model going forward.
Contents
Jump to a section
Update
Contract position from April 2026
The 2026/27 GP contract has been imposed and takes effect from 1 April 2026. Professional opposition and dispute activity may continue, but the implementation position for practices does not change.
For practice managers, the immediate operational point is straightforward: the financial and contractual changes below still need to be worked through, modelled and implemented from April.
Put less diplomatically, the contract may be politically unpopular, but your spreadsheet still has to survive it.
Download the briefings
Get the full PDF briefings
Need the full detail in a format you can save, share or take into a meeting? Download our PCN DES and QOF briefings for the full breakdown of funding shifts, threshold changes, points movements and operational watch-outs.
These PDFs are designed for practice managers, partners and PCN leaders who want the detail behind the headlines without having to excavate it from multiple annexes and contract documents.
The headline numbers in context
| Year | Uplift | Cash growth | Real growth | Total contract value |
|---|---|---|---|---|
| 2025/26 | £889m | 7.2% | 4.8% | £13,176m |
| 2026/27 | £485m | 3.6% | 1.4% | £13,863m |
The 2025/26 settlement was unusually large and included the autumn 2024 funding boost. By comparison, the 2026/27 uplift is more modest, but NHS England still presents it as real-terms growth against the GDP deflator.
The important shift is not just size. It is shape. The 2026/27 package moves more money into targeted routes, removes some visible item-based income, and ties more funding logic to measurable access delivery.
Where the £485 million actually goes
NHS England says the £485 million uplift includes Advice and Guidance funding, the QOF expansion, an assumed 2.5% pay uplift for 2026/27, premises inflation and other recognised cost growth pressures.
That wording matters. “Including Advice and Guidance funding” is not the same as preserving a separate ring-fenced payment stream. It means the old enhanced service funding has been folded into the overall contract package.
The same is true of the pay assumption. NHS England says the 2.5% figure will be revisited in light of pay review body recommendations. Practices should read that as a working assumption, not a finished answer.
Headline
Total GP contract uplift
QOF
Net additional QOF points worth about £25m nationally
Access shift
Repurposed into a practice-level GP reimbursement scheme
ARRS
Continues in 2026/27 for earlier GP ARRS cohorts
The £292 million practice-level shift
This is the biggest structural funding change in the 2026/27 contract.
At PCN level, the Capacity and Access Support Payment and Capacity and Access Improvement Payment are removed from the Network Contract DES. Together, those funding streams amount to roughly £292 million nationally.
That money is being redirected into a new practice-level GP reimbursement scheme. NHS England says practices will be able to use it to recruit additional GPs or increase sessions from GPs already working in the practice, with the stated purpose of strengthening clinically urgent same-day access.
Strategically, the direction is obvious. NHS England is choosing direct GP time at practice level as the access lever, rather than continuing to route the same money through PCN-level capacity and improvement mechanisms.
| Where the money came from | Where it goes now | What that means |
|---|---|---|
| CASP and CAIP at PCN level | Practice-level GP reimbursement scheme | Funding moves closer to the practice front door and is tied more directly to GP time and urgent access |
| Network-level access funding | Practice-level recruitment or extra sessions | NHS England is backing direct GP capacity over broader network-improvement routes |
| Relatively familiar PCN funding flow | New scheme with unpublished detail | Practices need to plan now, but should avoid treating unpublished mechanics as banked income |
What remains unclear in the published high-level material is the exact scheme detail: the distribution formula, claiming process, any weighting methodology, per-session reimbursement logic, local cap arrangements and how different sessional models will be treated.
What you are losing
Two clear income streams disappear in April, and both follow the same pattern: an optional enhanced service in 2025/26 becomes either a core contractual expectation or a QOF-based route in 2026/27, with the old per-item payment removed.
Income stream 1 gone
Advice and Guidance ES
The separate £20 per request payment disappears. The work remains, and the expectation to use A&G where clinically appropriate now sits inside the core contract.
Income stream 2 gone
Weight Management ES
The £11.50 per referral payment disappears. Obesity-related income now comes through the new QOF indicators OB004 and OB005 instead.
Advice and Guidance: from visible ES income to embedded contract funding
In 2025/26, the Advice and Guidance Enhanced Service paid practices £20 per eligible pre-referral request via e-RS, with national funding up to £80 million.
In 2026/27, the enhanced service is retired. Practices are now expected to use Advice and Guidance before planned care referrals where clinically appropriate and in line with local pathways, but there is no separate item payment.
Financially, that makes this one of the easiest places to overlook a real loss. The funding has not disappeared from the national contract envelope, but the identifiable practice-level income has.
| Advice and Guidance | 2025/26 | 2026/27 |
|---|---|---|
| Payment model | £20 per eligible request | No separate item payment |
| Contract status | Optional Enhanced Service | Expectation embedded into core contract where clinically appropriate |
| Funding treatment | Separate ES funding stream | Included within the total contract uplift |
The impact will vary dramatically between practices. If you used A&G lightly, the loss may be modest. If you were using it systematically, the disappearing visible income could be significant.
Weight Management: from £11.50 per referral to QOF points
In 2025/26, the Weight Management Enhanced Service paid £11.50 per referral to a structured weight management programme, with national funding of £7.2 million.
In 2026/27, the enhanced service is retired. Obesity-related income now sits inside QOF via two new indicators:
- OB004 – referral to weight management programmes: 5 points
- OB005 – shared decision-making and pharmacotherapy: 13 points
Together that gives 18 QOF points. Nationally, those additional points form part of the QOF expansion worth about £25 million.
Whether this is financially better or worse than the old enhanced service depends entirely on your current referral activity, register size, coding quality and likely achievement against the new thresholds.
| Weight management income route | 2025/26 | 2026/27 |
|---|---|---|
| Primary payment route | £11.50 per referral | QOF points via OB004 and OB005 |
| Income driver | Referral volume | Register, coding quality and threshold achievement |
| Operational implication | Simple ES logic | More dependent on consistent obesity workflow and accurate recording |
QOF 2026/27: the changes in detail
QOF 2026/27 is more than a rebasing exercise. Several indicators have been introduced, replaced or materially amended, and the threshold and points landscape has moved enough to make last year’s operating assumptions unsafe.
The biggest indicator changes at a glance
| Indicator | Change | Thresholds | Points movement |
|---|---|---|---|
| AF006 | Upper threshold increased | 40% to 95% | Unchanged at 12 points |
| CD001 | New blood pressure control indicator for CHD / stroke / TIA patients aged 79 or under without frailty | 40% to 90% | 41 reallocated points |
| CD002 | New blood pressure control indicator for CHD / stroke / TIA patients aged 80+ without frailty | 46% to 90% | 20 reallocated points |
| CHOL003 | Points reduced for consistency with lipid-lowering indicators | 70% to 95% | Reduced from 38 to 20 points |
| DM034 | Primary prevention statin indicator weighted more strongly | 50% to 90% | Increased from 4 to 8 points |
| DM035 | Secondary prevention statin indicator weighted more strongly | 50% to 90% | Increased from 2 to 8 points |
| DM037 | New annual diabetes care process indicator | 35% to 75% | 10 reallocated points |
| HF009 | New four-pillar HFrEF therapy indicator | 20% to 50% | 12 reallocated points |
| HYP010 | Cohort amended to remove moderately or severely frail patients | 40% to 85% | Unchanged at 38 points |
| HYP011 | Cohort amended to remove moderately or severely frail patients | 40% to 85% | Unchanged at 14 points |
| NDH003 | Gestational diabetes cohort added | 50% to 90% | Increased from 18 to 20 points |
| OB004 | New referral to weight management programmes indicator | 10% to 30% | New 5 points |
| OB005 | New shared decision-making and pharmacotherapy indicator for obesity | 50% to 80% | New 13 points |
| STIA007 | Ticagrelor added to qualifying antiplatelet list | 57% to 97% | Unchanged at 4 points |
| VI001 | Improvement threshold calculation added | 89% to 96% | Unchanged at 18 points |
| VI002 | MMRV added and improvement threshold calculation introduced | 86% to 96% | Unchanged at 18 points |
| VI003 | MMRV added and improvement threshold calculation introduced | 81% to 96% | Unchanged at 18 points |
Points movements should change local priorities
Some of the QOF point changes are large enough to alter the annual workload plan. CHOL003 falls sharply from 38 points to 20. DM034 doubles from 4 to 8. DM035 rises from 2 to 8. NDH003 increases from 18 to 20. New and reallocated indicators also pull attention into cardiovascular disease, diabetes, heart failure and obesity.
The practical message is simple: if a practice carries last year’s QOF priority stack forward unchanged, it risks spending time in the wrong places. Some previously dominant indicators now carry less weight, while newer or reworked indicators demand fresh implementation effort, tighter coding and more deliberate clinical ownership.
| Points movement | What it means in practice |
|---|---|
| CHOL003: 38 to 20 points | Still clinically important, but no longer one of the most dominant indicators in the points mix |
| DM034: 4 to 8 points | Primary prevention statin optimisation in diabetes carries more operational value |
| DM035: 2 to 8 points | Secondary prevention statin delivery in diabetes becomes much harder to treat as a minor indicator |
| NDH003: 18 to 20 points | Non-diabetic hyperglycaemia work grows slightly in both value and scope |
| CD001, CD002, DM037, HF009, OB004, OB005 | New and reallocated points shift workload toward fresh implementation rather than maintenance of old routines |
Childhood immunisations now have a second route to points
One of the most strategically important QOF changes in 2026/27 is the new improvement methodology for VI001, VI002 and VI003. Practices can now earn points either through the standard threshold model or through an improvement calculation based on performance uplift against baseline achievement, with the higher of the two calculations applying.
The improvement route only starts once a practice achieves at least a five percentage point improvement from baseline. Baselines are based on average annual achievement across 2024 to 2026. That matters because it gives lower-performing practices a more realistic route into points while still preserving the standard threshold model for practices that are already performing strongly.
Financially and operationally, this is a meaningful change. The childhood immunisation indicators no longer work only as a high-threshold model that mostly rewards already strong performers. They now also reward improvement, which should change how many practices think about recovery work, outreach and recall design.
| Indicator | Standard threshold range | Improvement threshold range | Points |
|---|---|---|---|
| VI001 | 89% to 96% | 5 to 18 percentage points improvement from baseline | 18 |
| VI002 | 86% to 96% | 5 to 23 percentage points improvement from baseline | 18 |
| VI003 | 81% to 96% | 5 to 30 percentage points improvement from baseline | 18 |
ARRS becomes materially more useful for GP recruitment
The single biggest workforce change is the widening of GP eligibility under the Additional Roles Reimbursement Scheme. The old rule limiting claims to recently qualified GPs has gone. In 2026/27, any GP can be eligible provided they have not been substantively employed as a General Medical Practitioner in a Core Network Practice of the PCN at any point in the previous 12 months.
The reimbursement ceiling rises sharply as well. The salary element of the maximum reimbursement increases from £82,418 in 2025/26 to £118,759 in 2026/27, or £120,921 in London. Once employer on-costs are included, the annual equivalent maximum reimbursement reaches £152,900 outside London and £155,698 in London. PCNs can also recruit a broader range of ARRS roles where locally agreed with the commissioner, including other non-direct patient care roles.
| ARRS GP change | 2025/26 | 2026/27 |
|---|---|---|
| Eligibility | Restricted to recently qualified GPs | Open to any eligible GP not substantively employed by a core practice in the PCN in the previous 12 months |
| Maximum salary reimbursement | £82,418 | £118,759 outside London / £120,921 in London |
| Maximum reimbursement including on-costs | Lower prior ceiling | £152,900 outside London / £155,698 in London |
| Recruitable roles | More constrained role set | Broader range of roles possible with commissioner agreement |
The minimum role requirements have also been updated for Social Prescribing Link Workers, Physician Associates, First Contact Physiotherapists, Dietitians, Podiatrists, Occupational Therapists, Paramedics and Advanced Nurse Practitioners. So this is not just a GP story. PCNs should assume their ARRS governance, templates and recruitment assumptions all need a refresh.
Capacity and Access Payment 2026/27: what practices need to do
One of the most important structural changes in the contract is the removal of the Capacity and Access Support Payment and Capacity and Access Improvement Payment from the Network Contract DES. In their place, NHS England is introducing a practice-level GP reimbursement scheme funded by the same £292 million. That shifts money that previously flowed through PCNs much closer to the practice front door.
The stated purpose is straightforward: practices use the funding to recruit additional GPs or increase sessions from GPs already working in the practice, with the aim of strengthening clinically urgent same-day access. Put simply, this is not a general uplift that can be absorbed into routine overhead. It is targeted GP capacity money tied to access.
| What is confirmed | What is still unclear |
|---|---|
| £292 million moves from PCN-level CAP into a practice-level GP reimbursement scheme | The exact distribution formula for individual practices |
| Funding is intended for new GP recruitment or additional GP sessions | Per-session reimbursement rates |
| The policy focus is clinically urgent same-day access | Any practice-level cap or allocation ceiling |
| Practices will be measured on access-related data | Whether locums or all sessional models qualify in the same way |
| GPs already employed through this funding can transfer to the new scheme | Whether high GP-to-patient ratio practices face a separate application route in every area |
The contract framework points in the same direction as the core access requirements: practices are expected to deal with requests identified as clinically urgent on the same day, they cannot ask patients to call back or make contact on another day, and online consultation systems must not cap requests during core hours. That means practices should not think about the new reimbursement scheme in isolation. It sits inside a broader access model that is becoming more explicit and more measurable.
The five access metrics now matter
Practice-level data collection will focus on five practical indicators that tell NHS England a lot about how access is working on the ground: call waiting time between 8am and 10am, call waiting time during core hours, the percentage of clinically urgent patients seen on the same day, the percentage of non-clinically urgent patients seen within one week, and the percentage seen within two weeks.
| Access metric | Why it matters operationally |
|---|---|
| Call waiting time between 8am and 10am | Measures how the practice handles the highest demand period of the day |
| Call waiting time during core hours | Shows whether access pressure is a peak-only issue or a full-day issue |
| Percentage of clinically urgent patients seen on the same day | Directly reflects compliance with the new same-day access expectation |
| Percentage of non-clinically urgent patients seen within one week | Shows whether routine access is still flowing while urgent demand is prioritised |
| Percentage of non-clinically urgent patients seen within two weeks | Indicates whether backlog or capacity slippage is building under the surface |
The rules leave the determination of clinical urgency to practices, which is sensible but also risky. The narrower your definition, the easier it becomes to show strong same-day performance. The broader it is, the more operational pressure you will create for yourself. Either way, practices need a consistent internal definition from day one. Otherwise the data becomes noisy, hard to defend and almost useless for improvement.
Three access rules practices should treat as live from day one
Same-day urgent response
Requests identified as clinically urgent must be dealt with on the same day.
No call-backs tomorrow
Practices must not ask patients to call back or make contact on another day.
No online caps in core hours
Online systems must not cap the number of requests patients can submit during core hours.
The practical challenge is that the phrase “dealt with” is broader than “seen face to face”. In most practices it will include triage, advice, remote clinical contact and a clear management decision as well as appointments. The important thing is not to pretend the rule does not exist. It does, and practices should define what same-day urgent handling means operationally inside their own access model.
Continuity, care homes, cancer and screening are all tighter
The DES now makes risk-stratified continuity a core requirement. PCNs are expected to identify and prioritise patients who would most benefit from continuity of care and build operational pathways around them.
Care home responsibilities are also broader: PCNs must make sure eligible aligned care home residents are identified and offered seasonal and routine vaccinations, whether delivered by the practice, the PCN or another provider under agreed arrangements. RSV has also been extended to all people aged 80 and over and all residents in care homes for older adults.
Cancer and screening requirements have also become clearer and more explicit. Referral quality is expected to align with NICE NG12, electronic safety-netting is now very much expected, and PCNs have clearer responsibilities for supporting eligible patients to take up cancer and non-cancer screening.
Participation, deadlines and governance still matter
PCNs with no membership or information changes continue automatically from 1 April 2026. Changes, opt-ins and opt-outs must be notified to commissioners by 30 April 2026.
On top of that, the General Practice Staff Survey is now a mandatory participation requirement for practices and PCNs, including sharing staff contact details with the ICB for personalised links.
Neighbourhood alignment is also now a live requirement in limited cases where geography clearly does not reflect local communities.
Free Practice Connect tools
Use our free tools to model your PCN funding and ARRS budget
The 2026/27 contract changes are much easier to understand once you run your own numbers. Our free tools help practices and PCNs turn the contract changes into something usable, whether you are planning workforce decisions, checking partner assumptions or trying to work out where the money has gone.
Use the PCN Split Calculator to model funding splits and core PCN income, and use the ARRS Budget Calculator to compare your current workforce plan against your allocation and reimbursement assumptions.
PCN Split Calculator
Enter your practice populations and care home figures to calculate your full PCN funding breakdown, including core income, ARRS, care home payments, enhanced access and other major components.
ARRS Budget Calculator
Enter the number of each ARRS role your PCN employs to calculate your total ARRS spend against your allocation and see how your workforce plan stacks up under the 2026/27 rules.
What to do on Monday morning
For practice managers
- Pull your 2025/26 Advice and Guidance claims and calculate the gross income that disappears with the ES.
- Pull your 2025/26 Weight Management ES claims and compare them with a realistic OB004/OB005 QOF scenario.
- Ask your QOF lead to model the point shifts, especially CHOL003, DM037, HF009, childhood immunisations and the obesity indicators.
- Do not treat the new practice-level GP reimbursement scheme as guaranteed income until the detailed rules are published.
- Start planning now how you would use the new scheme if the operational detail is favourable: new GP, extra sessions or another capacity model.
For PCN clinical directors and finance leads
- Review whether ARRS GP recruitment now becomes financially viable for your PCN in a way it was not before.
- Refresh ARRS governance and recruitment assumptions against the new eligibility and reimbursement rules.
- Check whether your PCN and member practices have a shared understanding of how the access obligations will work operationally.
- Review continuity, care home vaccination and screening expectations as operational cost issues, not just DES wording issues.
- Make sure nobody is assuming the £485 million headline flows neatly into unchanged practice income. It does not.